Rheumatology Advisor

Decrease in Rehospitalization With Remote Monitoring After Arthroplasty

January 22, 2021

A remote monitoring program does not affect the rate of discharge to home but does result in a reduction in rehospitalization in patients undergoing hip or knee arthroplasty.

Systemic Lupus Erythematosus

Identifying Risk Factors for Osteonecrosis in Patients With Systemic Lupus Erythematosus

By

Amit Akirov, MD

January 21, 2021

Researchers identified predictors of osteonecrosis in patients with systemic lupus erythematosus.

Anticoagulant efficacy to prevent VTE after hip and knee arthroplasty

Systemic Lupus Erythematosus

Hydroxychloroquine Levels Linked to Thrombosis Risk in Lupus

January 21, 2021

For patients with SLE lower hydroxychloroquine blood levels are associated with a higher risk for thrombotic events.

Rheumatoid Arthritis Advisor

Heart Disease in Rheumatoid Arthritis: Pathogenesis and Role of Treatment

By

Amit Akirov, MD

January 20, 2021

Patients with rheumatoid arthritis are at increased risk for ischemic and non-ischemic heart disease.

Rheumatoid Arthritis Advisor

Use of Rheumatoid Arthritis Disease Activity and Functional Status Measures in Telehealth Settings

By

Amit Akirov, MD

January 20, 2021

An expert panel was assembled by the ACR from prior RA disease activity and functional status measures in order to provide strategies for the modification and use of these measures in telehealth settings.

senior, elderly man taking prescription medication

Rheumatoid Arthritis Advisor

Predictors of Tocilizumab Treatment Outcomes in Patients with Rheumatoid Arthritis

By

Amit Akirov, MD

January 20, 2021

RA duration, alone or in combination with other baseline characteristics, had a statistically significant clinically small effect on the outcomes of toclizumab initiated in biologic naïve patients with rheumatoid arthritis.

Joint or cervical spine ankylosis may occur in RA.1 Joint ankylosis usually affects small joints of the hand, wrists, ankle, or forefoot. Although joint ankylosis was once common, widespread DMARD use has nearly eliminated this complication. Studies suggest that bone ankylosis is infrequent (0.8%) and usually occurs in patients with long-standing RA.1 Patients with joint ankylosis of the wrist appear more likely to develop cervical ankylosis.1 The reported prevalence of cervical spine ankylosis ranges from 9% to 80%, depending on the imaging modality used.1 Patients develop bony erosions, ligamentous laxity, and complete fusion.8 Ankylosis of the cervical facet joints typically occurs at the atlanto-occipital and atlanto-axial joints.9 Patients are often asymptomatic, but may have pain, neuropathy, or severe myelopathy and require surgical intervention. Use of DMARDs appears to prevent cervical ankylosis, but does not prevent its progression.8

Rheumatoid Arthritis Advisor

Persistence with TNFi Monotherapy After Achieving Disease Control on Combination Therapy

By

Emily Pond

January 20, 2021

This retrospective study of registry data reflecting real-world practice indicates patients who achieve remission/LDA with combination csDMARD and TNFi therapy may successfully transition to TNFi monotherapy.

Rheumatoid Arthritis Advisor

Comparing DAS28-ESR and DAS28-CRP in Patients with Rheumatoid Arthritis

By

Amit Akirov, MD

January 20, 2021

There is a difference between DAS28-ESR and DAS28-CRP, even when calculated for immunosuppressive treatment–naïve patients with rheumatoid arthritis.

Pediatric Rheumatology

Using Myositis-Specific Antibodies to Identify Phenotypic Subgroups of Juvenile Dermatomyositis

By

Emily Pond

January 19, 2021

Study authors investigated the link between anti-P155/140 and lipodystrophy, and between anti-P155/140 and damage to the nailfold capillary system in children with juvenile dermatomyositis.

pediatric patient examined in doctors office with parent

Pediatric Rheumatology

Novel Inflammation Marker May Predict Coronary Artery Lesions in Kawasaki Disease

By

Amit Akirov, MD

January 19, 2021

The C-reactive protein to albumin ratio is a novel inflammation marker that may be a valuable predictor of coronary artery lesion formation in Kawasaki disease.

Home

Decrease in Rehospitalization With Remote Monitoring After Arthroplasty

Identifying Risk Factors for Osteonecrosis in Patients With Systemic Lupus Erythematosus

Hydroxychloroquine Levels Linked to Thrombosis Risk in Lupus

Heart Disease in Rheumatoid Arthritis: Pathogenesis and Role of Treatment

Use of Rheumatoid Arthritis Disease Activity and Functional Status Measures in Telehealth Settings

Predictors of Tocilizumab Treatment Outcomes in Patients with Rheumatoid Arthritis

Persistence with TNFi Monotherapy After Achieving Disease Control on Combination Therapy

Comparing DAS28-ESR and DAS28-CRP in Patients with Rheumatoid Arthritis

Using Myositis-Specific Antibodies to Identify Phenotypic Subgroups of Juvenile Dermatomyositis

Novel Inflammation Marker May Predict Coronary Artery Lesions in Kawasaki Disease

Want to read more?

Pediatric Hospitalizations for COVID-19 Increasing Across US States